Visco Vision Inc. (TPE:6782)
181.00
-0.50 (-0.28%)
Nov 13, 2025, 1:35 PM CST
Visco Vision Revenue
Visco Vision had revenue of 1.08B TWD in the quarter ending June 30, 2025, with 18.89% growth. This brings the company's revenue in the last twelve months to 3.97B, up 29.98% year-over-year. In the year 2024, Visco Vision had annual revenue of 3.67B with 53.13% growth.
Revenue (ttm)
3.97B
Revenue Growth
+29.98%
P/S Ratio
2.87
Revenue / Employee
n/a
Employees
762
Market Cap
11.40B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.67B | 1.27B | 53.13% |
| Dec 31, 2023 | 2.40B | -379.85M | -13.68% |
| Dec 31, 2022 | 2.78B | 813.03M | 41.39% |
| Dec 31, 2021 | 1.96B | 438.11M | 28.70% |
| Dec 31, 2020 | 1.53B | 54.37M | 3.69% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bora Pharmaceuticals Co., LTD. | 21.32B |
| Lotus Pharmaceutical | 19.12B |
| PharmaEssentia | 13.82B |
| Pegavision | 6.90B |
| Center Laboratories | 1.57B |
| Oneness Biotech | 117.33M |
| Polaris Group | 70.83M |
| Lumosa Therapeutics | 37.25M |